Alanine Aminotransferase (ALT) Test Methods: A Comprehensive Technical Guide

Alanine aminotransferase (ALT) testing is one of the most widely performed clinical laboratory assays for evaluating liver function and detecting hepatocellular damage. This comprehensive guide covers the principle, sample requirements, testing methods, and clinical applications of ALT testing, providing laboratory professionals with essential technical knowledge for accurate and reliable results.

Technical Overview

Alanine aminotransferase (ALT), formerly known as serum glutamic pyruvic transaminase (SGPT), is a key enzyme found primarily in the cytoplasm of hepatocytes. ALT catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate, producing pyruvate and L-glutamate. When liver cells are damaged or destroyed, ALT is released into the bloodstream, causing serum ALT levels to rise significantly. Due to its high specificity for liver tissue and its concentration being highest in the liver, ALT measurement is considered one of the most sensitive indicators of hepatocellular injury.

The ALT test is typically performed as part of a liver function panel or hepatic panel, which often includes aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), bilirubin, and total protein measurements. The test is essential for diagnosing liver diseases, monitoring treatment efficacy, screening blood donors, and evaluating drug-induced liver injury (DILI).

Testing Samples

Serum Samples

Serum is the most common sample type for ALT testing. A venous blood sample of 3-5 mL is collected in a plain tube (without anticoagulant) or a serum separator tube (SST). The sample should be allowed to clot completely at room temperature for 30 minutes before centrifugation at 3000-4000 rpm for 5-10 minutes. Serum should be separated from the clot promptly to prevent hemolysis-related interference.

Plasma Samples

Plasma can also be used for ALT testing, typically collected in heparinized tubes. Some testing platforms are validated for plasma use, but it is important to confirm that the specific method and instrument are approved for plasma samples. Plasma samples should be centrifuged within 2 hours of collection.

Sample Storage and Stability

ALT is relatively stable in serum under proper storage conditions. The following guidelines should be observed:

• Room temperature (20-25°C): Stable for up to 24-48 hours
• Refrigerated (2-8°C): Stable for up to 7 days
• Frozen (-20°C or below): Stable for up to 1 month
• Repeated freeze-thaw cycles should be avoided as they may cause enzyme degradation
• Severe hemolysis may falsely elevate ALT results due to intra-erythrocyte enzyme release

Testing Items

The ALT test measures the enzymatic activity of alanine aminotransferase in serum or plasma. The primary testing items and related parameters include:

• ALT activity level (measured in U/L or IU/L)
• AST/ALT ratio (De Ritis ratio), useful for differential diagnosis of liver diseases
• Reference intervals, typically 7-56 U/L for males and 5-43 U/L for females (may vary by laboratory and method)
• Clinical decision limits for specific conditions (e.g., >10 times ULN suggests acute hepatitis)
• Serial ALT measurements for monitoring disease progression or drug toxicity

Testing Methods

Continuous Monitoring Method (Kinetic Method)

The International Federation of Clinical Chemistry (IFCC) recommends the continuous monitoring (kinetic) method as the reference method for ALT determination. This method is based on a coupled enzymatic reaction system. In the first step, ALT catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate, forming pyruvate and L-glutamate. In the second step, pyruvate is reduced to lactate by lactate dehydrogenase (LDH) with simultaneous oxidation of NADH to NAD+. The rate of decrease in NADH absorbance at 340 nm is directly proportional to ALT activity.

The reaction principle is as follows:

• L-Alanine + α-Ketoglutarate → Pyruvate + L-Glutamate (catalyzed by ALT)
• Pyruvate + NADH + H+ → Lactate + NAD+ (catalyzed by LDH)
• The decrease in absorbance at 340 nm is measured spectrophotometrically

This method offers high sensitivity, good precision, and automation compatibility, making it the standard method in modern clinical laboratories worldwide.

Reitman-Frankel Method (Colorimetric Method)

The Reitman-Frankel method is a traditional endpoint colorimetric method for ALT determination. In this method, ALT catalyzes the formation of pyruvate, which then reacts with 2,4-dinitrophenylhydrazine (DNPH) to form pyruvate hydrazone. The hydrazone product is alkalified with sodium hydroxide to produce a brown-red color, and the absorbance is measured at 505-530 nm. The ALT activity is determined by comparing the absorbance to a standard curve. Although this method is less precise and more susceptible to interference than the kinetic method, it may still be used in resource-limited settings.

Dry Chemistry Method

Dry chemistry (solid phase chemistry) systems use multilayer film slides or test strips impregnmented with reagents. A small drop of sample is applied to the slide, and the enzymatic reaction occurs within the dry reagent layers. Reflectance spectrophotometry is used to measure the color change. This method requires minimal sample volume and no liquid reagent preparation, making it suitable for point-of-care testing and small laboratories.

Point-of-Care Testing (POCT)

Portable devices for rapid ALT measurement have been developed for on-site screening, particularly useful in blood donor screening, clinical trials, and remote settings. These devices typically use disposable test strips or cartridges with a small fingerstick blood sample and provide results within minutes.

Quality Control and Calibration

To ensure accurate and reliable results, laboratories should implement a comprehensive quality assurance program:

• Use of certified reference materials or calibrators traceable to IFCC reference procedures
• Regular participation in external quality assessment (EQA) or proficiency testing programs
• Daily internal quality control using at least two levels of control materials (normal and elevated)
• Regular instrument maintenance and calibration verification
• Adherence to pre-analytical, analytical, and post-analytical quality protocols

Applications

ALT testing has extensive applications in clinical medicine, pharmaceutical research, and public health:

• Diagnosis and monitoring of acute and chronic hepatitis (viral, alcoholic, autoimmune, and drug-induced)
• Assessment of liver damage in cirrhosis, liver fibrosis, and non-alcoholic fatty liver disease (NAFLD)
• Monitoring hepatotoxicity in patients receiving potentially hepatotoxic medications, including antituberculosis drugs, antiretroviral therapy, and chemotherapy
• Screening blood donors for transfusion-transmissible infections and liver abnormalities
• Evaluation of liver injury in occupational and environmental toxic exposure cases
• Pre-employment and routine health examination screening
• Clinical trial safety monitoring for new drug development
• Differential diagnosis of jaundice and liver diseases when combined with other liver function tests

FAQ

What are the normal reference ranges for ALT?

Normal ALT values typically range from 7 to 56 U/L for males and 5 to 43 U/L for females. However, reference intervals may vary depending on the testing method, instrumentation, and population studied. Each laboratory should establish its own reference intervals based on the local population and validate them according to clinical laboratory standards.

What factors can cause elevated ALT levels?

Elevated ALT levels can be caused by various conditions including viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, drug-induced liver injury, autoimmune hepatitis, cirrhosis, liver ischemia, and strenuous physical exercise. Certain medications, obesity, and heavy alcohol consumption can also cause mild to moderate ALT elevations.

How should I prepare for an ALT test?

Generally, no special preparation is required for an ALT test. However, patients may be advised to avoid alcohol consumption and strenuous exercise for 24-48 hours before the test, as these can temporarily elevate ALT levels. Some laboratories prefer fasting samples for consistency, especially when multiple tests are performed simultaneously.

What does a very high ALT level indicate?

ALT levels exceeding 10 times the upper limit of normal (>500-1000 U/L) typically suggest acute liver injury, most commonly due to acute viral hepatitis, ischemic hepatitis, toxic hepatitis, or acute drug-induced liver injury. Immediate clinical evaluation and further diagnostic workup are warranted in such cases.

Can ALT testing be performed on hemolyzed samples?

Severely hemolyzed samples are not recommended for ALT testing because red blood cells contain ALT and LDH, which can cause falsely elevated results. Mild hemolysis may be acceptable depending on the laboratory's rejection criteria, but visual or automated hemolysis assessment should be performed before analysis.

What is the difference between ALT and AST testing?

ALT is primarily found in the liver, while AST is present in the liver, heart, skeletal muscle, kidneys, brain, and red blood cells. ALT is more specific for liver damage, whereas AST elevation can indicate injury to multiple organs. The AST/ALT ratio (De Ritis ratio) is clinically useful: a ratio >2 suggests alcoholic liver disease, while a ratio <1 is more typical of viral hepatitis and non-alcoholic fatty liver disease.